The startup develops medical cannabis formulations using biotechnological methods to enhance the efficacy and accessibility of cannabis-based medicines. By aligning production processes with pharmaceutical standards, the company enables medical cannabis producers to create cost-effective treatments that meet regulatory requirements.
Funding
$22.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients face challenges in accessing consistent, high-quality medical cannabis treatments due to variations in production standards and regulatory requirements. This inconsistency affects the efficacy and cost-effectiveness of cannabis-based medicines, limiting their accessibility for those who could benefit.
Solution
Grow Group addresses these challenges by developing medical cannabis formulations using advanced biotechnological methods, ensuring both efficacy and accessibility. The company aligns its production processes with stringent pharmaceutical standards, enabling medical cannabis producers to create cost-effective treatments that meet regulatory requirements. Through its vertically integrated and partner model, Grow Group ensures a broad supply of differentiated cannabis medicines, driving better patient outcomes. The company's focus extends to innovation in processing technologies, precise dose control, and tailored delivery mechanisms, enhancing the overall quality and reliability of medical cannabis products.
Target Audience
The primary target audience includes medical cannabis producers, healthcare professionals, and patients seeking reliable and cost-effective cannabis-based treatments for various conditions such as chronic pain, anxiety, depression, epilepsy, and other conditions.
Features
- Development of medical cannabis formulations using biotechnological R&D.
- Pharmaceutical-grade production processes to ensure consistency and quality.
- Technologies for cheap, accurate, and rapid production of medicinally-effective cannabis compounds.
- Precise dose and ratio control for increased bioavailability and stability.
- Tailored measured dose devices for cannabis, particularly for inhalation.
- A Patent Class for Selective Recovery of Hydrophobic Compounds.
- An issued patent for Modified Surface Technology.
- A patent application for Pharmaceutical Compositions for Vaporisation and Inhalation.